Clinical trial
A Study of OSI-7904L Versus 5-FU/LV as Treatment in Patients With Biliary Tract…
NCT00088270 · OSI Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00088270 |
|---|---|
| Title | A Study of OSI-7904L Versus 5-FU/LV as Treatment in Patients With Biliary Tract Cancer |
| Official title | A Randomized, Open Label, Phase II Study of OSI-7904L Versus 5-FU/LV as First-Line Treatment in Patients With Unresectable, Locally Advanced or Metastatic Adenocarcinoma of the Biliary Tract |
| Lead sponsor | OSI Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Locally Advanced or Metastatic Adenoca of the Biliary Tract |
| Intervention type | Drug |
| Interventions | OSI-7904L, 5-Fluorouracil/Leucovorin |
| Enrollment | 58 |
| Start date | Aug 1, 2004 |
| Completion | Aug 1, 2005 |
| First posted | Jul 26, 2004 |
| Last update posted | Feb 22, 2006 |
| Countries | Belgium, Germany, Poland, Romania, Switzerland, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: